BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 21, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2015
View Archived Issues
Sage Therapeutics reports results from completed phase I/II trial of SAGE-547 in SRSE
Read More
Daiichi Sankyo reports highlights of fourth quarter of fiscal 2014
Read More
Otsuka Pharmaceutical updates progress of first quarter 2015
Read More
Cortendo licenses rights to ATL-1103 for endocrinology applications
Read More
Blueprint Medicines describes FGFR-4 inhibitors
Read More
TopiVert initiates phase I study of TOP-1288 for ulcerative colitis
Read More
New model of mature B-cell lymphoma developed, revealing possible treatment strategy
Read More
Preliminary first-in-human phase I results presented for RBL-001/RBL-002
Read More
Synovo compound SYD-003 has potential for treating prostate cancer
Read More
NCCN awarded ImmunoGen's grant for mirvetuximab soravtansine in FR alpha-positive cancers
Read More
Actavis launches Namzaric in U.S.
Read More
Endpoints not met in phase III study of EBI-005 for dry eye disease
Read More
Caltech to use OMT's UniRat to generate nanobodies against HIV-1
Read More
FDA grants fast track designation to AG-120 for patients with AML and IDH1 mutation
Read More
DNA-YFVax shows promise as an alternative to expensive YFV vaccines
Read More
U.S. fast track designations for luspatercept in beta-thalassemia
Read More
Endotoxin-induced uveitis model demonstrates dynamic changes in M1 and M2 macrophages
Read More
TRF1 identified as a novel target for treating lung cancer
Read More
Synta Pharmaceuticals patents SDC-TRAP compounds
Read More
Lilly discloses SGLT1 inhibitors
Read More
Merck & Co. reports development of GCGR antagonists
Read More
Johnson & Johnson expands policy to enhance access to darunavir
Read More
FGFR-4 inhibitors reported in Novartis patent
Read More
Pluristem's PLX program selected for EMA's Adaptive Pathways pilot project
Read More
Durect releases results from phase I study of oral DUR-928
Read More
Endo International agrees to acquire Par Pharmaceuticals
Read More
PlasmaTech Biopharmaceuticals completes acquisition of Abeona Therapeutics
Read More
